Skip to main content
Clinical Trials/TCTR20240320003
TCTR20240320003RecruitingPhase 2

Effectiveness of Hyperbaric Oxygen Therapy and Conventional Treatment Versus Conventional Treatment Alone in Patients with Frozen Shoulder ; a Multicenter Randomized Controlled Trial.

Queen Sirikit Naval Hospital0 sites60 target enrollmentStarted: March 20, 2024Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 Years to 60 Years (—)
Sex
All

Inclusion Criteria

  • 1. Diagnosis of frozen shoulder
  • 2. Be diagnosed both before and after ethical approval of this proposal, from any primary doctor.
  • 3. Onset of shoulder pain at least 2 months and not more than 9 months, as a first phase of frozen shoulder.
  • 4. Normal radiographic study.
  • 5. Consent to join the study.
  • 6. Able to continue treatment protocol for 5 days.

Exclusion Criteria

  • 1. History of previous shoulder trauma.
  • 2. History of previous shoulder surgery.
  • 3. History of previous shoulder infection.
  • 4. History of inflammatory joint disease.
  • 5. History of malignant.
  • 6. History of shoulder injection with corticosteroids or nonsteroidal anti-inflammatory drugs (NSAIDs)
  • 7. Contraindication to hyperbaric oxygen therapy such as untreated pneumothorax, lung cyst, and uncontrolled seizure.
  • 8. Allergy or contraindication to nonsteroidal anti-inflammatory drugs (NSAIDs) or omeprazole such as gastrointestinal bleeding, chronic kidney disease, chronic liver disease, and current aspirin use from other medical condition.

Investigators

Sponsor
Queen Sirikit Naval Hospital

Similar Trials